SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-24-001683
Filing Date
2024-05-10
Accepted
2024-05-10 16:14:02
Documents
40
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zk2431397.htm   iXBRL 10-Q 603202
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 11857
3 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES OXLEY ACT OF 2002 exhibit_31-2.htm EX-31.2 11973
4 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES OXLEY ACT OF 2002 exhibit_32-1.htm EX-32.1 4072
5 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES OXLEY ACT OF 2002 exhibit_32-2.htm EX-32.2 4149
  Complete submission text file 0001178913-24-001683.txt   3274257

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE entx-20240331.xsd EX-101.SCH 53211
7 XBRL CALCULATION FILE entx-20240331_cal.xml EX-101.CAL 24822
8 XBRL DEFINITION FILE entx-20240331_def.xml EX-101.DEF 66393
9 XBRL LABEL FILE entx-20240331_lab.xml EX-101.LAB 775618
10 XBRL PRESENTATION FILE entx-20240331_pre.xml EX-101.PRE 155964
43 EXTRACTED XBRL INSTANCE DOCUMENT zk2431397_htm.xml XML 220140
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38556 | Film No.: 24935003
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)